ESCMID Study Group for Viral Hepatitis - ESGVH

News & Activities

An ESGVH survey

Management of HCV infection in patients with haematological malignancies

The ESGVH Executive Committee has endorsed a survey on the management of HCV infection in patients with haematological malignancies.  This survey aims to evaluate the willingness of DAAs prescribers to treat HCV infection during chemotherapy in patients with aggressive lymphoma, and report on the attitude of DAAs prescribers towards anticipating or delaying HCV treatment according to the presence of active haematological malignancies and transplant-related procedures. This survey might provide interesting data on the crucial issue of management of chronic HCV infection in this subset of immunocompromised patients.

To fill in the survey, please click on the following link until 19 January 2020. Feel free to share this link with your colleagues. Thank you.

ESCMID Postgraduate Education Course

Elimination of Viral Hepatitis: Are We Ready?

Co-organised by ESGVH, TAE and ESCMID

27 – 28 September 2019, Ljubljana, Slovenia

Viral hepatitis remains a global public health problem that represents a constant challenge for ID/CM specialists. In 2016 the first ever WHO global health sector strategy set goals to eliminate viral hepatitis as a public health threat by 2030. With highly effective HCV treatment and highly effective hepatitis B vaccine the goal seems achievable. However, there are several barriers to be overcome from the diagnostic, clinical, institutional as well as the patient sites. The goal of this course is to present the current epidemiological situation, clinical achievements and remaining issues of the five viruses, HBV and HCV in particular, the goals of WHO elimination strategy, the barriers to achieve elimination goals and some solutions to overcome the barriers in different resource settings. Additional benefit of the course is also in discussing the role of ID/CM specialists and their readiness towards the elimination of viral hepatitis.


Course material in the ESCMID eLibrary

New Executive Committee takes office

ESGVH has a new executive committee composed of:

  • Chairperson: Dr Andrea Lombardi, Italy
  • Treasurer: Berend Joost Van Welzen, Netherlands
  • Secretary: Boun Kim Tan, France

The new executive committee was elected at the annual meeting for a term of two years.

ESCMID Postgraduate Education Course

Workshop on Migrants’ Health

Co-organised by ESGCP, ESGVH, ESGEM, ESGMYC, the Ministry of Health of Oman, the ESCMID Task Force for Emerging Infections (EITaF), WHO EMRO, ECDC

8 – 10 March 2018 Muscat, Oman

Course Objectives: to highlight the initiatives for monitoring migrants’ health, prevent and control infectious diseases in migrants in GCC and EMRO; to discuss the impact of migrants on the health systems of the hosting countries especially for vaccine preventable diseases, importation of communicable diseases and AMR; to present the ways to enhance GCC / EMRO preparedness for infectious diseases in migrants during peace and conflict; to highlight the importance of intergovernmental and international organizations collaboration required to address migrants’ health needs in GCC / EMRO; to discuss the role and impact of migrants on the elimination programs for TB, malaria, HIV and hepatitis B and C viruses, and what strategies countries can follow to address the challenge; to discuss the ways on how countries can establish surveillance and integrated research for migrants’ health


Course material in the ESCMID eLibrary